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Ticks infest a variety of animal species and transmit pathogens causing disease in both humans and 
animals worldwide. Tick-host-pathogen interactions have evolved through dynamic processes that 
accommodated the genetic traits of the hosts, pathogens transmitted and the vector tick species that 
mediate their development and survival. New approaches for tick control are dependent on defining 
molecular interactions between hosts, ticks and pathogens to allow for discovery of key molecules 
that could be tested in vaccines or new generation therapeutics for intervention of tick-pathogen 
cycles. Currently, tick vaccines constitute an effective and environmentally sound approach for the 
control of ticks and the transmission of the associated tick-borne diseases. New candidate protective 
antigens will most likely be identified by focusing on proteins with relevant biological function in the 
feeding, reproduction, development, immune response, subversion of host immunity of the tick vector 
and/or molecules vital for pathogen infection and transmission. This review addresses different 
approaches and strategies used for the discovery of protective antigens, including focusing on relevant 
tick biological functions and proteins, reverse genetics, vaccinomics and tick protein evolution and 
interactomics. New and improved tick vaccines will most likely contain multiple antigens to control 
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Diseases caused by arthropod-borne pathogens account for over 20% of all emerging infectious 
diseases recorded between 1940 and 2004 (1). Ticks are considered to be second worldwide to 
mosquitoes as vectors of human diseases and the most important vectors of diseases that affect animal 
health worldwide, with the largest effect on the cattle industry (2, 3). It is therefore evident that ticks 
and their associated transmitted pathogens constitute a growing burden for human and animal health 
worldwide (4, 5). Tick control has been primarily based on the use of chemical acaricides resulting 
in partial efficacy and enhanced selection of resistant tick populations (6). Therefore, new 
approaches are needed for effective control of ticks and their associated tick-borne diseases, of 
which vaccines appear to be an effective and environmentally sound option (6). 
The only commercially available vaccines against ectoparasites were developed and registered in the 
early 1990s for the control of cattle tick infestations (7). These vaccines are based on recombinant 
Rhipicephalus microplus BM86/BM95 antigens and demonstrated the important advantages of being 
a cost-effective and environmentally friendly alternative with a dual effect of reducing tick 
infestations and preventing ticks from transmitting disease-causing pathogens (7). The protective 
mechanism characterized for BM86/BM95 tick vaccines is based on the development of antigen-
specific antibodies in immunized hosts that interact and subsequently affect the biological function of 
the targeted antigen within the tick tissues, impairing tick feeding on the immunized hosts (7-9). The 
application of the BM86/BM95-based vaccines results in reduction of the number, weight and 
reproductive capacity of engorging female ticks, resulting in a gradual reduction in tick infestations in 
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The application of commercial vaccines for the control of cattle ticks demonstrated that tick vaccines 
also constitute an effective and environmentally sound approach for the control of tick-borne diseases 
(TBDs) (7). However, despite recent advances in the identification and characterization of candidate 
tick vaccine antigens, new tick and pathogen derived protective antigens need to be identified to 
increase vaccine efficacy for the control of TBDs (6, 10). Herein, we review some of the major 
approaches and strategies that are currently being used for the identification of protective antigens, as 
well as some future trends to develop improved tick vaccines.  
FROM TICK BIOLOGY TO TICK VACCINES: A RATIONAL APPROACH 
The rational approach towards discovery of promising vaccine candidates that will impair biological 
processes, stem from our knowledge of specific features in tick physiology that evolved during the 
adaptation of an ancestor mite to an obligatory blood-feeding lifestyle. Therefore, the processes 
associated with tick attachment to the host, followed by undisturbed feeding on the host, intracellular 
digestion of the large amount of ingested blood and finally, processing of the blood-meal into huge 
clutches of eggs laid by the engorged females. To date, this approach has offered a number of 
potential vulnerable targets (Achilles’ heels) that could be affected by antibodies present in a 
vaccinated hosts. In this section we will enumerate the physiological processes that are targeted to 
date (Figure 1) and link the research findings to our current understanding and approaches for the 
development of efficacious tick vaccines.  
Tick attachment and on-host feeding  
Blocking attachment of a tick to the host would be the ultimate goal, impairing not only tick feeding 
but also transmission of tick-borne pathogens. The process of attachment starts with the intrusion of 
the tick mouthpart (hypostome) into the host dermis, followed by anchoring of the tick by a cement 
cone that is mostly comprises of secreted glycine-rich proteins (11). 
Several cement cone antigens have been identified based on their immunogenicity. Screening of a 
cDNA expression library from Haemaphysalis longicornis females, with rabbit immune serum raised 
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protein HL 34 (that is rich in tyrosine and proline residue repeats) (13). Immunization of rabbits with 
recombinant P29 caused about 50% mortality of H. longicornis larvae and nymphs (12). 
Immunization with recHL 34 reduced survival of both immature and adult H. longicornis stages. The 
appearance of ticks fed on vaccinated hosts point to impaired blood-meal uptake and digestion (13).  
Two vaccine candidates were identified from the cement cone of the African brown ear tick, 
Rhipicephalus appendiculatus. A highly immunogenic glycine-rich protein RIM 36 has the potential 
to be developed into a diagnostic marker for detection of cattle that have been exposed to feeding 
ticks, however its protective effect as a vaccine has not been assessed (14). In contrast, a secreted 15 
kDa protein called 64P seems to be invisible to the host immune response most likely given its 
similarity to the mammalian skin keratins (15). The N-terminal portion of 64P displays similarity with 
the α2 chain of collagen type IV and exhibited very promising protection in animal trials when 
expressed as truncated 64P constructs (64TRPs) with GST as a fusion protein. The vaccine based on 
64TRPs was reported to have a ‘dual action’ as tick feeding on immunized animals was primarily 
impaired at the skin feeding site, but cross-reaction of anti-64TRP antibodies with midgut antigenic 
epitopes also caused rupture of the tick midgut and death of engorged ticks (15). In addition, several 
64TRPs exhibited a cross-protective response against other tick species, namely Rhipicephalus 
sanguineus and Ixodes ricinus, underscoring their potential as a broad-spectrum tick vaccine (16). 
Intriguingly, it was later demonstrated in a mouse model that vaccination with 64TRPs antigens 
protected mice against lethal transmission of tick-borne encephalitis virus (TBEV) by still unknown 
mechanisms (17). However, these results were obtained in rodent models (guinea pigs and mice), with 
no evidence that it is effective in protection against tick infestation in natural hosts such as cattle.  
Proteases and protease inhibitors at the tick-host interface 
Tick saliva is an extremely rich cocktail of bioactive compounds that facilitates ixodid ticks to feed 
undisturbed on the host for several days. Our knowledge about the molecules produced by tick 
salivary glands (sialomes) increased dramatically during the past decade due to high-throughput 
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host hemostasis, immune and inflammatory response are members of multigene families. This 
observation may lower the potential of individual saliva molecules as vaccine candidates given their 
extreme redundancy, but other possibilities to target these antigens during vaccination are discussed 
later in this paper. Despite the great redundancy of these proteins, some promising results have been 
reported for tick proteases and protease inhibitors involved in tick-host interactions. 
Metalloproteases 
The protective ability of Metis 1, a member of a putative metalloprotease family from salivary glands 
of I. ricinus (19), was tested on rabbits immunized with recombinant Metis 1. Vaccination had no 
effect on tick attachment and mortality, but reduced the engorgement weight of I. ricinus females and 
their ability to lay eggs (20). A slight increase in mortality (some 15%) was reported for H. 
longicornis nymphs and adults fed on rabbits vaccinated with recombinant metalloprotease HLMP1 
(21). Most recently, protective potential of the R. microplus metalloprotease BrRm-MP4 against R. 
microplus was tested in cattle trials. The overall efficacy of vaccination with recombinant BrRm-MP4 
was 60%, mainly reducing the number of engorged ticks that completed feeding on immunized cattle 
(22). 
Protease inhibitors 
A number of host defense reactions such as blood coagulation and complement activation are 
mediated by cascades of serine proteases (23). Recombinant serine protease inhibitors (serpins) from 
several tick species have been examined as candidate vaccine targets. HLS2 from H. longicornis 
resulted in some 40% mortality of nymphs and adults fed on immunized rabbits (24, 25). Four serpins, 
termed RAS-1-4 identified from R. appendiculatus (26), were tested either as a mix of recombinant 
RAS-1 and RAS-2 (27) or as a cocktail composed of three antigens, RAS-3, RAS-4 and the immune-
dominant RIM36 (28). Immunization of cattle with recombinant RAS-1 and RAS-2 reduced the 
number of engorged R. appendiculatus nymphs by 60% and increased mortality of adult males and 
females by 43% and 28%, respectively (27). A combination of RAS-3, RAS-4 and RIM6 mainly 
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from I. ricinus, exerted a significant protective immunity against nymphs and adults fed on vaccinated 
rabbits as displayed by increases in mortality (~ 30%), reduced weight of engorged ticks and 
prolonged feeding time. No effect was obtained for nymphs fed on vaccinated mice (29). 
 
Another group of tick protease inhibitors that are considered as possible candidate antigens are 
cystatins, that inhibit a variety of cysteine peptidases involved in modulation of host immunity and 
inflammation (30). Sera from guinea pigs that were repeatedly exposed to tick infestation did not 
recognize sialostatin L2, a secreted immunomodulatory cystatin from Ixodes scapularis salivary 
glands. This antigen was subsequently termed a ‘silent’ antigen by the authors (31). It does however 
need to be confirmed that this observation is not due to the antigen not being processed in antigen 
presenting cells, versus being secreted into an environment where immune-suppression is occurring 
due to tick saliva proteins. After all, a vast number of salivary gland proteins are not recognized by 
immune-sera, but they remain immunogenic upon vaccination. Nevertheless, feeding of I. scapularis 
nymphs on guinea pigs vaccinated with Sialostatin L2 was impaired as early rejection of the nymphs 
occurred as well as a reduction in the ability of remaining nymphs to imbibe blood (31). Similar 
results were reported for the cystatin OmC2 from the soft tick, Ornithodoros moubata. Vaccination of 
mice with recombinant OmC2 significantly reduced the number of O. moubata first nymphal stage 
capable to complete feeding, resulting in increased post engorgement mortality (32). As OmC2 is 
expressed in both the salivary gland and gut tissues of O. moubata, the authors speculated about a 
possible ‘dual’ action that impairs both feeding (via interfering with modulation of host immune 
response) and blood digestion (32). More recently, identification and characterization of cystatins 
from other tick species, namely R. appendiculatus, R. microplus and Ixodes ovatus, were reported and 
the immunogenicity of corresponding recombinants tested as a first step towards their assessment as 
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Water balance  
Osmoregulation and water balance play an extremely important role in tick physiology as a fully 
engorged ixodid female tick can imbibe 200-300 times her own weight of host blood. The blood meal 
is concentrated in the gut with about 70% of the fluid being returned to the host via salivation (11, 
36). Therefore, water channels (aquaporins), present another rational target for vaccine development 
(37, 38). The function of aquaporin was examined in I. ricinus by RNAi silencing of an aquaporin 
termed IrAQP1, resulting in 50% weight reduction of semi-engorged females that fed for 5 days.  
Vaccination experiments remain to be performed for IrAQP1 (39). Three aquaporins have been 
identified in the cattle tick R. microplus, and the vaccination potential of RmAQP1 was recently 
tested. Two independent pen trials (conducted in Brazil using Holstein-Friesian calves vaccinated 
with Pichia-expressed recombinant RmAQP1) exerted a high efficacy with 75% and 68% decrease 
respectively, in the number of adult ticks that completed feeding (40). This result promotes RmAQP1 
among the most promising vaccine candidates that should be further tested against cattle ticks in 
different geographic regions. More recently, stage and tissue expression profile and functional 
assessment by RNAi was reported for R. microplus aquaporin 2 (RmAQP2) (41). RmAQP2 was 
found predominantly expressed in the salivary glands of semi-engorged females, and RNAi-mediated 
silencing resulted in a minor increase of the body weight of engorged females, pointing towards 
impairment of the osmoregulatory system. No vaccination effect with recombinant RmAQP2 has been 
reported to date. 
Blood digestion 
Blood meal processing occurs intracellularly within the digestive cells of the tick gut epithelium (11) 
and is performed by an orchestrated network of acidic peptidases comprising aspartic endopeptidases 
of the cathepsin D-type, cysteine endo- and exopeptidases of the papain-type (cathepsin L, B a C) and 
asparaginyl endopeptidases of the legumain-type (for review see (42)). This multi-enzyme digestive 
apparatus may seem to offer multiple potential antigens for efficient tick control, as suggested by the 










This article is protected by copyright. All rights reserved. 
to our knowledge, no successful vaccination experiment using a recombinant tick digestive enzyme 
has been reported to this end. Experimental vaccination of rabbits with a cocktail of recombinant 
cathepsins D, B, L, C and legumain from I. ricinus have been performed (45). Despite high antibody 
titres against all of the recombinant antigens, only a slight increase in the mortality of I. ricinus 
females was observed in two of the three vaccinated rabbits. Currently, the potential of targeting 
multiple tick digestive peptidases by vaccination is limited given the high redundancy of the system, 
as previously demonstrated by specific inhibition of a subset of enzymes (46). The possibility of 
targeting unique protein-protein interaction sites that may be more evolutionary conserved, is 
discussed later in this paper. 
Heme and iron metabolism 
Ticks have to cope with an excess of toxic heme and iron-derived metabolites from their blood meal. 
The majority of heme is detoxified via its accumulation in organelles called hemosomes (47) of which 
only a small portion is used for tick’s own metabolic demands as they are not capable of heme 
biosynthesis (48, 49). The non-heme iron is sequestered intracellularly by ferritin 1 (Fer1), which is 
related to mammalian heavy-chain ferritins (50). Their expression was shown to be post-
transcriptionally regulated by an iron-responsive protein (IRP) (51). Transport of non-heme iron from 
the tick gut to peripheral tissues is mediated by a secreted ferritin 2 protein (Fer2) that is distinct from 
tick ferritin 1 and mammalian ferritins (51). The critical functions of tick ferritins in tick development 
and reproduction was demonstrated by RNAi-mediated silencing in I. ricinus (51) and H. longicornis 
(52, 53). To date, much emphasis has been placed on tick Fer2 as it displays other desired attributes 
expected from an ideal concealed antigen, including: (i) not being present in the mammalian host; (ii) 
it is encoded by a single gene (no redundancy problem); (iii) it is expressed in the gut and therefore 
can come into contact with antibodies taken up by a bloodmeal from a vaccinated host, and  (iv) it 
was shown to be highly immunogenic as a recombinant protein. In the first pilot experiments, 
vaccination of rabbits with recombinant Fer2 from I. ricinus substantially reduced tick infestation, 
weight of engorged females and their fertility with an overall efficacy of 98% (54). In the same study, 
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efficacy of about 60% (which was similar to that of the Bm86 antigen used as positive control) in 
protection against R. microplus. Some 70% protection was observed against R. annulatus (54). The 
vaccination potential of Fer1 and Fer2 from H. longicornis has been evaluated using a rabbit model. 
Immunization with recombinant H. longicornis Fer2 resulted in a significant reduction of body weight 
with reduced oviposition and hatching observed for both groups immunized with Fer1 and Fer2 (55). 
Most recently, the vaccination potential of other molecules possibly playing a role in tick heme and 
iron metabolic pathways of I. ricinus, was screened using RNAi and experimental vaccination of 
rabbits (56). In addition to Fer1, Fer2 and IRP (see above),  RNAi screening also evaluated 
transferrin2 (Trf2), a divalent metal transporter 1 (Dmt1), ferrochelatase (Fech), heme-binding 
lipoprotein (HeLp), heme responsive gene 1 (HRG1) and vitellogenins 1 and 2 (Vg1, Vg2). Results 
from both RNAi and vaccination studies concluded that none of these molecules surpassed Fer2 with 
regards to their impact on tick development and reproduction efficiency. 
Detoxification 
Glutathione S-transferases (GSTs) from numerous parasites have been shown to play an important 
role in metabolic detoxification of xenobiotics, reactive oxygen species, heme and other toxic 
compounds, and as such present as a promising antigens for anti-parasitic vaccines (57, 58). The 
protective potential of one such GST was examined using H. longicornis GST in cattle trials against 
R. microplus infestations (59). Given its cross-reactivity with other tick proteins, three out of four 
calves immunized with recombinant H. longicornis GST displayed some 50% reduction of engorged 
R. microplus adults. 
Mating 
The ability of ixodid females to initiate and complete the rapid engorgement phase of feeding is 
determined by their mating status. An engorgement factor that is passed from males to females during 
copulation was identified in Amblyoma hebraeum and termed voraxin (60). It is composed of two 
unrelated peptides tagged AHEFα and AHEFβ of 16.1 kDa and 11.6 kDa, respectively. During 
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normally mated A. hebraeum females were capable to fully engorge (60). The potential of voraxin as 
a vaccine candidate was also evaluated against R. appendiculatus. Immunization of rabbits with 
recombinant voraxin α reduced the weight of engorged R. appendiculatus ticks by some 40% and also 
significantly impaired subsequent oviposition and larval hatching efficacy (61). 
Vitellogenesis and feritility 
Impairment of vitellogenesis, embryogenesis and fertility by vaccination would be meaningful 
especially to control the population of one-host ticks such as R. microplus. Three enzymes involved in 
vitellogenin processing in R. microplus eggs have been identified and characterized to date. These 
include two aspartic peptidases, the Boophilus yolk pro-cathepsin (BYC) (62) and tick-heme binding 
aspartic peptidase (THAP) (63), as well as a cathepsin L-like vitellogenin degrading cysteine 
endopeptidase (VTDCE) (64). Bovine immunization was performed with native or recombinant BYC 
and VTDCE and the individual enzymes conferred only limited protection (some 25%) in overall 
efficacy (65-68). A combination of recombinant BYC and VTDCE and the previously mentioned 
GST from H. longicornis was evaluated as a cocktail vaccine in field conditions (69). The number of 
semi-engorged females fed on the vaccinated cattle was reduced by about 50%, which seems to 
correlate with increased body weight gain in the vaccinated calves. This desired result further 
underscores the potential of multi-antigenic vaccines that might be capable to provide protection 
against ticks, and maybe also against the diseases they transmit. 
REVERSE GENETICS APPROACH TO TICK VACCINES 
Tick genomic and sequence resources  
Innovations in genome sequencing technologies have progressed the fields of reverse genetics and 
reverse vaccinology. Fewer genome projects have been developed for tick species due to their large 
genome sizes and the presence of dense repetitive regions. For example the genome sizes for I. 
scapularis and R. microplus were estimated at 2.1 Gb and 7.1 Gb respectively, with repetitive 
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following a pattern of short period interspersions (70). Since this publication in 2005, the I. scapularis 
genome assembly was reported at 3.8x coverage from 369,495 scaffolds built using 570,637 contigs 
with a total number of 20,486 coding genes (Genbank accession: ABJB000000000.1 Ixodes 
scapularis strain Wikel colony; (71)). A preliminary 1.8 Gb of the R. microplus gene enriched 
genome sequence has been reported (72). McCooke et al. (73) reported that CattleTickBase is a 
database that contains all of the sequences from the R. microplus genome sequencing project, 
presently at ~ 4X coverage with Pac Bio (74).  Thus the sequencing of the whole R. microplus 
genome is proceeding with only preliminary data published to date including several BAC clones and 
the mitochondrial genome of the Deutsch Texas R. microplus strain (73, 75). Recently, preliminary 
genome sequence data for Ixodes ricinus was reported with ~998 million paired-end reads (~47x 
coverage, approximately 63% of the total coding sequences) from Illumina HiSeq™ next generation 
sequencing (GenBank accession numbers: JXMZ01000000 and SRP051465) (76). Due to the 
complexity of tick genomes, EST and next generation transcriptome sequencing projects have been 
undertaken to inform researchers in terms of the identity of specific genes up-regulated by different 
organs in feeding ticks, particularly salivary glands (sialome) and/or the mid-guts (mialome). 
Although EST libraries have been used to develop custom microarrays to examine up- and down-
regulation of tick genes in different samples (77, 78), this review will focus on sequencing 
technologies only. Table 1 provides examples of EST and transcriptome sequencing studies for 
selected tick species.  
Introduction to reverse genetics and applications to tick research  
Forward genetics methods in eukaryotes have been used for more than 100 years to identify the 
gene(s) responsible for a particular phenotype, reviewed by Hardy et al. 2010 (79). Reverse genetics 
consists of modifying the activity of a target gene to determine the phenotypic consequences. 
Modifications to the genome are implemented by random chemical or insertional mutagenesis (e.g. 
transposons or retroviruses), or specifically using homologous recombination of a target gene (79). 
Other approaches targeting mRNA include morpholino antisense oligonucleotides and RNA 
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exogenous or endogenous double stranded RNAs to knockdown specific transcripts (80). For reverse 
genetics approaches, ideally the whole genome sequence is required in order to screen and predict the 
specificity of these knockdown treatments. In addition, genome sequencing has identified genes with 
unassigned functions. Assigning functions to these genes can be achieved by predicting subcellular 
localizations of gene products and by describing the phenotypes associated with their disruption (79). 
Thus essentially high-throughput reverse genetics approaches are major tools in the post-genomic era. 
A challenge with tick sequence analysis is the presence of a large number of genes whose functions 
are both unknown and unpredicted. These have been called ‘orphan genes’ which lack detectable 
sequence homology to genes in pre-existing databases (81). For ticks, the most exploited reverse 
genetic approach has been RNAi (82). For the most part, tick researchers have developed dsRNA 
treatments in the absence of complete genome sequences despite strong evidence for ‘off-target-
effects’ demonstrated in model organisms as well as ticks (83, 84). Model genome sequences have 
also been mined to identify homologues in tick species of interest. For example, the investigation of 
R. (B.) microplus RNAi phenotypes utilized Drosophila melanogaster (fruit fly) homologues for 
cellular viability (85). In addition, to identify proteins associated with the tick RNAi pathway, fly and 
nematode homologues were used to mine R. microplus EST sequences (86) and available I. scapularis 
genome reads. Thirty-one putative proteins were identified including a putative tick Dicer, RISC 
associated proteins and an RNA dependent RNA polymerase not previously identified in arthropod 
species (85).  
Predictive algorithms for reverse vaccinology based tick vaccine candidate identification 
Reverse vaccinology (RV) is defined as the screening of all open reading frames that a particular 
pathogen can express at any time followed by the screening for protective immunity as the ‘rate 
limiting’ step (87). RV has so far been successful for the development of novel anti-bacterial vaccines 
with relatively small genomes in comparison to ectoparasites such as ticks (88). With the completion 
of the I. scapularis genome, this provides an opportunity to develop a tick specific RV approach. 
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complete whole genome data. One study has used a B cell epitope prediction program (BCPREDS) to 
examine I. scapularis salivary proteins, however in vivo confirmation of the immunogenicity of these 
proteins was not demonstrated (89). In addition, 24 hour fed I. scapularis tick saliva proteins were 
expressed using phage display and panned using antibodies to identify immunogenic proteins which 
could affect early feeding events including pathogen transmission, with no further testing reported 
(90). A reverse vaccinology approach for soft ticks has been described as a concept paper only (91).  
The most researched tick species in terms of reverse vaccinology approaches has focused on the 
identification of vaccine candidates to protect against the cattle tick R. microplus species complex 
(including R. australis and specific clades of R. microplus and R. annulatus) (92), Table 2. These ticks 
collectively vector babesiosis and anaplasmosis to susceptible cattle across cattle populations 
worldwide causing widespread losses (93, 94). One approach mined the BmGI EST database 
available in 2007 and sequences from subtraction library experiments (86, 95) for specific Pfam 
database (96) signatures of putative antigenic proteins (97). Localization of the Pfam identified 400 
ESTs included qRT-PCR analysis of different tick stages and organs collected from susceptible and 
resistant breeds of cattle and secretion predictions (SignalP), followed by the prediction of linear B 
cell binding epitopes using Bepipred (97, 98). Antibodies produced against peptides recognized by 
tick resistant breeds of cattle were fed to semi-engorged female ticks in vitro (99), and the 
corresponding peptides of the antibodies causing damage to ticks fed in vitro are currently being 
tested in cattle vaccine trials (97). Another approach was based on a ‘systems biology’ analysis of 
transcriptome datasets and RNAi screening of potential candidates identifying an aquaporin protein 
found to be protective against R. annulatus and R. microplus challenge at 68% and 75% respectively 
(40, 100). A third approach utilized the screening of the same BmGI EST database (86) using a 
custom microarray to screen different stages and organs of ticks.  Functional annotations were 
undertaken prior to analysis using VaxiJen, which was developed to predict protective antigens of 
bacterial, viral and tumor origin (101). Mouse antisera were used to pre-screen the putative 
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Limited uses of algorithms have been applied for the identification of putative tick vaccine antigens 
using the above RV approaches. A limitation in the use of linear B cell predictions above (BCPREDS 
and Bepipred) is based on the fact that up to 90% of B cell epitopes are known to be conformational 
and not linear (102). With R. microplus EST resources used (97, 101), many of the sequences would 
have been incomplete thus the determination of conformational B cell epitopes was not possible 
without access to a fully annotated tick genome. Databases such as AgAbDb have been established 
based on co-crystal structures to assist to determine conformational B cell epitope structures (103). 
Many predictive tools have been developed to predict protein domains, secretion, transmembrane 
helices, GPI anchor, cellular localization and immune binding epitopes (104, 105). There is a lack of 
ectoparasite specific tools for immuno-informatics analyses that have been tested or confirmed, with 
most tools reported to date developed based on bacterial and viral antigen discovery. 
RV tick research approaches have also been limited by the absence of fully annotated tick genomes. 
In addition, it is predicted that ticks have ~20,000 coding genes compared to ~3,000 (average) for 
bacteria. For bacteria, the comparison of multiple genomes (pan-genomics) have been recently added 
to RV pipelines to improve the robustness of antigen predictions (106). Perhaps the future for tick 
vaccines will be the analysis of several genomes within and between species, to develop novel generic 
globally applicable tick vaccines. As genome sequencing technologies continuously improve, there 
are many options to consider for the future of tick vaccine development.  
VACCINOMICS APPROACH TO TICK VACCINES 
The challenge of developing improved vaccines against ticks and transmitted pathogens arises from 
the need to understand the complex molecular relationship between vertebrate hosts, ticks and 
pathogens which requires a systems biology approach that will allow the integrated analysis of 
metabolomics, transcriptomics, proteomics and other omics data for discovery of key pathways and 
molecules that mediate ticks-host-pathogen interactions. A vaccinomics approach could then be used 
to identify and fully characterize candidate protective antigens in different tick and pathogen species 
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Towards an integrated systems biology approach for tick vaccine development 
Vaccinomics in this article refers to a holistic approach based on the use of genome-scale or omics 
technologies and bioinformatics in a systems biology approach for the development of next-
generation vaccines (107). The scientific principle underlying a systems biology approach to tick 
vaccine development is that ticks, hosts and pathogens have evolved molecular interactions that affect 
their survival and life cycle and this co-evolution involves genetic traits of the tick vectors, vertebrate 
hosts and pathogens. Vaccinomics is therefore seen as translational research, in which basic biological 
information on tick-host-pathogen interactions translates into the identification and subsequent 
evaluation of new vaccines. The pipeline and the methods proposed for tick vaccinomics were 
described recently (107, 108) (Figure 2). 
The systems biology approach to the characterization of the molecular mechanisms that mediate tick-
host-pathogen interactions identifies host/tick response and infection-transmission factors and will 
likely provide new targets for the control of tick infestations and/or pathogen infection and 
transmission (107). Omics data integration should be followed by the identification of candidate 
protective antigens using a combination of different screening platforms to formulate and test 
vaccines in controlled pen trials and under field conditions (107). Finally, the biological function and 
protective mechanisms elicited by vaccination should be characterized to provide additional 
information to design improved vaccines based on the combination of antigens with different 
functions to produce a synergistic effect upon vaccination (107). The integration of omics databases 
for the identification of candidate protective antigens and the characterization of the immune 
mechanisms by which protective and non-protective responses to vaccines are generated are the major 
challenges in vaccinomics (107, 109). Recent results using the Ixodes scapularis-host-Anaplasma 
phagocytophilum model illustrated the possibilities of these new technologies for the identification of 
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Characterization of I. scapularis-host-A. phagocytophilum interactions 
Transcriptomics and proteomics have been used for the characterization of I. scapularis-host-
A. phagocytophilum molecular interactions (18, 110, 111). However, only recently the 
integration of additional datasets from metabolomics studies has been applied to the study of 
the I. scapularis-A. phagocytophilum interface (112-116). The results of these analyses 
showed that A. phagocytophilum has evolved common molecular mechanisms to establish 
infection in tick vectors and vertebrate hosts (111). These strategies include, but are not 
limited to, remodeling of the cytoskeleton, inhibition of cell apoptosis, manipulation of the 
immune response and the use of rickettsial proteins for infection and manipulation of tick and 
host gene expression (111).  
Vaccinomics approach for the identification of candidate tick protective antigens 
For the proof of concept of the vaccinomics approach in ticks, a pipeline was designed based on 
proteins identified as involved in tick-pathogen interactions (107). These proteins were selected as 
candidate protective antigens based on their putative role in tick-Anaplasma marginale  [Silk; (117)], 
tick-Babesia bigemina [Trospa; (118)] and tick-pathogen [Subolesin; (119)] interactions. First, 
transcriptome analyses were combined with RNAi studies to identify Silk and Trospa as candidate 
protective antigens (117, 118). Tick Subolesin, the ortholog of insect and vertebrate Akirin, was 
discovered in 2002 as a tick protective antigen in I. scapularis by expression library immunization in 
a mouse model of tick infestations (120). Both transcriptomics and RNAi experiments have shown its 
role as a transcription factor required for the regulation of different processes including the innate 
immune response to pathogen infection (119, 121, 122). Then, in vitro capillary feeding was used to 
characterize their potential as antigens for the control of both cattle tick infestations and infection with 
A. marginale and B. bigemina (123). Recombinant proteins were produced in Escherichia coli, 
purified and used to generate antibodies in rabbits. Purified rabbit polyclonal antibodies were added to 
uninfected or infected bovine blood to capillary-feed female R. microplus ticks. Capillary-fed ticks 
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shown when compared to controls fed with blood alone (123). However, no effect was observed on 
pathogen DNA levels in capillary fed ticks (123). Nevertheless, these results together with previous 
results of functional studies by RNAi suggested that these proteins are promising vaccine antigens for 
the control of R. microplus infestations and infection with A. marginale and B. bigemina and 
supported the conduction of vaccine trials to validate these antigens (9). Vaccination studies showed 
that vaccination with Silk and Subolesin, but not Trospa, reduced tick infestations and oviposition 
with respect to ticks fed on placebo-treated control cattle (124). Furthermore, the results also showed 
that vaccination with Trospa and Subolesin reduced B. bigemina DNA levels in ticks while 
vaccination with Silk and Subolesin resulted in lower A. marginale DNA levels when compared to 
ticks fed on placebo control cattle (124). 
These results prove the validity of the vaccinomics approach to select protective antigens and show 
that vaccines using tick proteins involved in vector-pathogen interactions could be used for the dual 
control of tick infestations and pathogen infection. Remarkably, vaccination with Subolesin has 
shown an effect on the reduction of infestations by different ectoparasites and infection by different 
pathogens, therefore suggesting the possibility of developing vaccines for the control of multiple 
ectoparasites and infection/transmission of vector-borne pathogens (6). Additionally, vaccinomics 
approach also results in the identification of pathogen-derived candidate protective antigens (116). In 
this way, the combination of tick-derived with pathogen-derived antigens might results in more 
effective vaccines for the control of tick-borne diseases (6). 
INSIGHT FROM TICK PROTEIN EVOLUTION: TARGETING OF 
BINDING SPECIFIC EPITOPES (PROTEIN-PROTEIN 
INTERACTIONS) AND CONSERVED METABOLIC PATHWAYS 
 
From a previous section of this paper describing the genomes sizes and repetitive nature of tick 
genomes, one is faced with questions pertaining to the origin(s) and significance of these large tick 
genomes and its impact on vaccine design. Leading studies from the group of Ben J Mans, have 
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evidence that at least one genome duplication event occurred for ticks (125-127). Evidence is growing 
on how rapid ticks can adapt to new climates, host species and challenges set by the use of acaricides, 
stressing their ability to acquire novel properties and functions within a short period of time. The 
adaptability of parasitic organisms has been ascribed to various factors including gene duplication, 
molecular chaperones, antigenic variation, polymorphisms, molecular mimicry, rapid turnover of 
surface molecules and gene disruption to name but a few (128-133). In ticks, gene duplications are 
most likely one of the strongest driving forces (125-128, 131, 133).  Therefore, our understandings of 
tick evolution, protein structure and function are vital in the search of new and improved tick 
vaccines. Furthermore, current data indicates that hard and soft ticks adapted independently and that 
the large protein families seem to be lineage specific expansions that occurred after their divergence. 
This strongly suggests that a universal tick vaccine is non-viable and that focus should be placed on 
finding targets within subsets of closely related tick genera or even species. Cautions should thus be 
placed on extrapolating the protective abilities of a specific antigen between tick species, as was seen 
in the case of Bm86 vaccines (134-139) and a vast number of antigens that failed to protect against 
different tick species across different hosts (as summarized in (140).  
Evaluation of all animal vaccine trials done to date indicate that single antigens display only some 40-
60% protection under controlled conditions (140). From experience, we know that these levels of 
protection will be greatly reduced under field conditions. This should stress the need to develop 
combinatorial tick vaccines and to expand our ideas on what a “targetable” genome may be in ticks. 
For example, a proteome’s complexity arises not only from the proteins three-dimensional structure 
(lower level information), but also from its functional interactions (higher level). This suggests an 
organized modularity for a proteome with connections to regulators, mediators and adaptors, all 
opening up a huge new complexity for therapeutic intervention. 
We are entering an era where our understanding of how ticks evade vaccination and immune 
responses with their highly repetitive genomes, and how to formulate our vaccines to ensure that 
protective eiptopes remain accessible is vital. To date, only two examples of promising combinatorial 
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reverse vaccinology approach (Table 2) (41). Although not fully understood, the functions of BM86 
and Subolesin are most likely to be different based on the phenotypes observed after vaccination with 
individual antigens and the subcellular localization of the antigens. Based on this consideration, a new 
vaccine formulation containing a combination of BM86 and Subolesin was recently patented claiming 
synergy between these antigens resulting in higher vaccine efficacy against cattle tick infestations (6). 
The true mechanism underlying the protective ability of the latter combination, as well as the reverse 
vaccinology-derived combination remains to be elucidated.  
Protein-protein interactions (PPIs) and Metabolic Pathways 
It is well known that protein sequences are more conserved than their coding nucleotide sequences, 
and that protein folds are more conserved than the amino acid sequences encoding them. Even more 
conserved, are the active site residues of enzymes and the binding specific epitopes occurring in 
protein-protein interactions. Proteins function not merely as single entities, but display their roles by 
interacting with other cellular components, as seen in the case of signaling pathways and signal 
transduction, cytoskeleton arrangement and re-arrangement, biological recognition in the immune 
system, enzyme regulation and gene expression (141). In ticks, transcriptome analyses have identified 
proteins acting in almost all of the latter pathways, but no studies have been performed to validate 
core pathways and to better understand the PPIs occurring in these pathways.  Without this 
information, our understanding of tick biology and number of vaccine candidates and drug targets that 
can be evaluated remains inefficient.  
In the case of developing vaccines against parasites such as Plasmodium (the causative agent of 
malaria), Mycobacterium tuberculosis and Toxoplasma (the causative agent of toxoplasmosis), PPIs 
have shaped the field significantly as it filled major gaps in the knowledge of parasite biology and 
provided new vaccine targets, screens for parasite-host interactions and defining protective versus 
decoy conformational epitopes which may have a tremendous impact on the potential of antigens as 
protective vaccine candidates (Figure 3) (142-151). To date only limited studies on Bm86 have 
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mechanism(s) used by ticks to overcome Bm86 vaccination are available, indicating that homologous 
Bm86 coding areas are expressed in R. appendiculatus (155). No characterization of proteins that 
cross-react with immune sera (as is the case with sera raised against subolesin that show significant 
cross-reactivity) has been attempted. If one considers gene duplications in tick genomes, tick proteins 
may well make use of “misleading” surfaces with immunogenic epitopes, which will not necessarily 
be protective epitopes. This raises questions to the number of antigens that failed in animal trials and 
are being discarded as potential vaccine candidates  
In ticks, only a single yeast two-hybrid study has been conducted, resulting in the identification of 
binding-partners of subolesin (121). Since then, additional cDNA libraries have been cloned into 
various two-hybrid bait and prey plasmids, resulting in the identification of additional protein-protein 
interactions in R. microplus (patents pending). The protective ability of these protein-protein 
interacting antigens is currently being evaluated in cattle vaccine trials. Recently, surface plasmon 
resonance was used to confirm the protein-protein interaction between boophilin from R. microplus 
and thrombin (156). In combination with the available crystal structure data (157), this opens an 
exciting era to evaluate the use of protein binding epitopes as vaccines and to screen peptide and 
chemical libraries for small molecules or peptides capable of disrupting the protein-protein 
interactions between boophilin and thrombin. 
 
With regards to PPIs involved in vector-pathogen-mammalian host interphases, the Borrelia 
burgdorferi field (causative agent of Lyme disease) is setting the trend with interactions described for 
BB0323 and BB0323 (158, 159) as well as OspA and CD40 (160). Additional targets of interest 
include the tetratricopeptide repeat domain of BB0238 (161) and La7 (162). Currently, interactomes 
of tick tissues of interest for vaccination as well as the tick-pathogen and tick-host interphases remains 
unexplored. Since most tick proteins are not annotatable using standard computational tools, the use 
of in silico method to predict PPIs will may of limited use and we may have to rely on classical 
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arrays, large scale co-immunoprecipitation studies and mass spectrometry to initiate the field. For 
predicting pathogen-host interactions, in silico methods may prove valuable, as supporting large 
datasets are available to be used as scaffolds (146, 163-166). 
 In addition to PPIs, another strategy to improve current vaccines involves the simultaneous targeting 
of antigens that function within a conserved metabolic pathway that occur in related tick species. In 
ticks, this has been evaluated to some extend by targeting gut proteins involved in tick digestion (as 
described in this paper).  In 2015, a study by van Zyl et al. attempted to identify transcripts involved 
in metabolic pathways that are conserved in both R. microplus and R. decoloratus gut tissue. Chi-
square analysis revealed that genes involved in lipid transport and metabolism are significantly 
overrepresented in both species (167). Since then, the data was subjected to metabolic pathway 
analysis and key antigens selected, produced using recombinant E. coli and shown to be 
immunogenic. Vaccine trials using these combinatorial antigens are in process. In conclusion, RNA-
seq and DNA microarray analyses have identified tick proteins involved in a number of metabolic 
pathways all of which remains to be evaluated for PPIs and possible combinatorial vaccines targeting 
conserved metabolic pathways.  
 
CONCLUSIONS AND FUTURE DIRECTIONS 
Tick vaccines to date focused on targeting important biological processes (predominantly tick 
attachment and digestion) with the use of single antigens. Although these studies provided much 
needed insight into tick biology, it failed to provide full protection against tick infestations. Based on 
our growing knowledge of tick genome complexity and protein superfamilies, we are entering a new 
era that will require of us to understand the mechanism used by ticks to overcome changes in their 
environments (such as in the presence of vaccines or acaricides) and to expand our knowledge on the 
“targetable” genome of ticks. In this regard, reverse vaccinology, protein-protein interactions 
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Studies on ticks and the tick-host-pathogen interactions suggest that a combination of pathogen-
derived ligands and/or tick/host receptors and other tick protective antigens will be needed in vaccines 
(6). In this way, the vaccine containing vector and pathogen-derived antigens may protect vertebrate 
hosts against tick infestations and pathogen infection while also decreasing pathogen transmission and 
therefore the risk of disease in humans and animals. 
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Figure legends 
Figure 1. An overview of tick physiological processes and involved molecules tested as vaccine 
candidates.  For abbreviations, tick species and references see the corresponding paragraphs in the 
text. Underlined – the most promising rationally designed vaccine candidates.  
 
Figure 2. Vaccinomics pipeline for the development of vaccines for the control of tick 
infestations and pathogen infection/transmission. Vaccinomics refers to a holistic approach based 
on the use of genome-scale or omics technologies and bioinformatics for systems biology analysis of 
host-tick-pathogen interactions for the development of next-generation vaccines.  
 
 
Figure 3. Schematic presentation of immunogenic eiptopes and protein binding epitopes. A tick 
attached to the host secrets a number of salivary gland proteins into the feeding pool. Outside of the 
feeding pool, blood coagulation can occur as normal (cluster of purple and red cells). The effect of 
generating antibodies against immunogenic eiptopes (yellow boxes) are shown for one of the tick 
proteins, as well as the ability of the tick protein to remain biological active bind continous binding to 
its host target protein (host factor). The protein-protein binding sites (PPIs) are indicated with orange 
boxes. By targeting these PPIs, it may be possible to disrupt biological activity of tick salivary gland 
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Table 1. Examples of EST and transcriptome sequencing studies for selected tick species 
 
Species Life stages 
sequenced 
Technology Output Ref. 
Amblyomma 
americanum 
Larvae, nymph, adult 




14, 310 ESTs (81)
Amblyomma triste,  




nymphs (A. triste 
only) 




Dermacentor andersoni  Salivary glands from: 
unfed, 2 and 5 day fed 
(female adults) 
454 Roche 21,769 CDSs (169)
Haemaphysalis flava Female salivary 
glands 
Illumina 54,357 transcripts (170)
Ixodes ricinus 
 













Larvae and female 
salivary glands 
Illumina ~over 27,000 
transcripts 
(173)
Ixodes scapularis Nymphs and female 
midguts and salivary 
glands 
Illumina 17,503 transcripts (114)
ISE6 cells Illumina 37,990 transcripts (115)
Rhipicephalus 
haemaphysaloides 
Unfed and fed female 
salivary glands 
Illumina/Solexa 25,113 transcripts; 
cysteine proteases up-
regulated in feeding 
ticks 
(174)
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Species Life stages 
sequenced 
Technology Output Ref. 
(Boophilus) microplus feeding female ticks, 















Table 2. Reverse genetics and high throughput reverse vaccinology approaches applied for tick 
vaccine candidate identification. 
 
Species Reverse genetics approaches Data or vaccine 
output 
Reference
Ixodes scapularis Linear predictions of B-cell 
epitopes in salivary proteins 
(BCPREDS) 
Not tested (89) 
Phage display of 24h tick saliva 








Secreted salivary proteins and 
concealed mid-gut antigens 
shown to be critical to the 
function of the tick; low copy 
number gene; and shared 
conserved epitopes among several 
tick species 




Gene discovery (EST library, 
subtraction libraries, microarray 
analysis, CattleTickBase), 
Bepipred predictions of linear B-
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screening, predicted SignalP and 
localisation screening, anti-B cell 
peptide antibody in vitro tick 
feeding  
EST library, DNA microarrays, 
membrane and secreted proteins, 
VaxiJen, mouse antiserum 
screening 
On-going (101) 
Systems biology, CattleTickBase, 
RNA interference screening, in 
silico antigenicity 
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